Tag: viral vector manufacturing market growth

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

How is the Viral Vector Manufacturing Market Expected to Expand from 2024 to 2033?

The market size of viral vector manufacturing has seen substantial growth in the past few years. It is projected to expand from $5.82 billion in 2023 to $7 billion in 2024, with a compound annual growth rate (CAGR) of 20.4%. The notable growth during the historic period can be associated with the increase in the gene therapy pipeline, successful clinical outcomes and approvals, substantial investment in biopharmaceuticals, and a heightened prevalence of genetic disorders.

The market for viral vector production is predicted to witness a substantial surge in the upcoming years, culminating in a total market worth of $14.55 billion by 2028, registering a compound annual growth rate (CAGR) of 20.0%. This projected escalation for the period can be credited to its diversified uses in the field of oncology, worldwide cooperation in gene therapy exploration, the integration of viral vectors in vaccine production, continuing clinical trials, and commercialization. The principal trends projected for this duration encompass technological advancements in vector manufacturing, the emergence of advanced generation vectors, regulatory adherence and standardization, partnerships and collaborations, and global extension of manufacturing establishments.

Claim Your Free Sample of the Global Viral Vector Manufacturing Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12398&type=smp

What Influences Are Propelling the viral vector manufacturing Market Forward?

The rise in the instances of cancer and infectious diseases is projected to bolster the expansion of the viral vector manufacturing market in the future. The term infectious disease pertains to a disorder induced by a virus or its poisonous byproduct and is conveyed to a susceptible host through touch with a person, animal, or object that is infected. Cancer is a term that encompasses a multitude of diseases that occur anywhere in the body when rogue cells evolve out of control, exceed their usual limits to encroach on neighboring organs, and disseminate to other organs. Viral vectors are utilized to create tumor antigens, proteins found on tumor cells, to instigate the body’s anticancer immune reaction. Viral vectors have been employed as vaccines against a variety of infectious diseases in both preclinical and clinical studies. For example, in May 2022, the World Health Organization, a specialized health agency in Switzerland, reported that the malaria case count in 2021 was 247 million, a slight increase from 245 million in 2020. Additionally, in June 2023, the Centers for Disease Control and Prevention, a US-based branch of the Department of Health and Human Services, reported 1,603,844 new cancer cases and 602,347 cancer-related deaths in the US in 2020. As a result, the rise in instances of both cancer and infectious diseases is propelling the growth of the viral vector manufacturing market.

What Key Segments Exist Within the Viral Vector Manufacturing Market?

1) By Type: Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types

2) By Disease: Cancer, Genetic Disorders, Infectious Diseases, Other Diseases

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research

5) By End-User: Research Organizations, Biotech And Pharmaceutical Companies, Others End Users

What Trends Are Coming to the Forefront in the Viral Vector Manufacturing Market?

The trend of product innovation is witnessing a surge in the viral vector manufacturing market. Major players in the market are leveraging product innovations to maintain their market standing. For example, Merck KGaA, a German-based company dealing in science and technology, launched the VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform in August 2022. It was among the first Contract development and manufacturing organizations and technology developers to provide a comprehensive viral vector manufacturing solution, inclusive of AAV, Lentiviral, CDMO, CTO, and process development. This innovative platform aids biopharmaceutical companies in reducing the costs and duration of process development while speeding up the time it takes to manufacture clinically.

Order Now for Fast Delivery of Your Viral Vector Manufacturing Market Report!

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

What Regions Are Leading the Charge in the Viral Vector Manufacturing Market?

North America was the largest region in the viral vector manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Viral Vector Manufacturing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the viral vector manufacturing market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Viral Vector Manufacturing Market Include

1. Viral Vector Manufacturing Market Executive Summary

2. Viral Vector Manufacturing Market Segments

3. Viral Vector Manufacturing Market Size And Template Market Growth Rate

4. Key Viral Vector Manufacturing Market Trends

5. Major Viral Vector Manufacturing Market Drivers

……

25. Key Mergers And Acquisitions In The Viral Vector Manufacturing Market

26. Top Viral Vector Manufacturing Companies

27. Viral Vector Manufacturing Market Opportunities And Strategies

28. Viral Vector Manufacturing Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Contract Development Manufacturing Organizations Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/contract-development-manufacturing-organizations-global-market-report

Metal Manufacturing Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/metal-manufacturing-global-market-report

Automotive Manufacturing Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/automotive-manufacturing-equipment-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Viral Vector Manufacturing Global Market Report 2024, the viral vector manufacturing market is expected to show significant growth in the forecast period.

The viral vector manufacturing market has witnessed exponential growth in recent years, with promising forecasts indicating further expansion. Let’s delve into the factors driving this growth and the trends shaping the market landscape.

Exponential Growth and Projections:

• The market size surged from $5.82 billion in 2023 to $7 billion in 2024, boasting a remarkable compound annual growth rate (CAGR) of 20.4%.
• Projections suggest a continued upward trajectory, with expectations of reaching $14.55 billion by 2028 at a CAGR of 20.0%.

Drivers of Growth:

• Pipeline of Gene Therapies: The burgeoning pipeline of gene therapies has been a significant contributor to market expansion.
• Clinical Success and Approvals: Increasing clinical successes and regulatory approvals have fueled market growth.
• Investment in Biopharmaceuticals: Heightened investment in biopharmaceuticals has propelled the demand for viral vectors.
• Prevalence of Genetic Disorders: Rising prevalence of genetic disorders has necessitated advancements in viral vector manufacturing.

View More On The Viral Vector Manufacturing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Impact of Rising Cancer and Infectious Diseases:

• Prevalence Surge: The rise in cancer and infectious diseases worldwide is a primary catalyst for market growth.
• Applications in Oncology: Viral vectors are increasingly utilized in oncology for tumor antigen production and immune response elicitation.
• Vaccine Development: Viral vectors play a crucial role in vaccine development against infectious diseases.
• Clinical Trials and Commercialization: Continued clinical trials and commercialization efforts drive market expansion.

Product Innovation Driving Market Dynamics:

• Introduction of Innovative Platforms: Major players are introducing innovative platforms to streamline viral vector manufacturing processes.
• Merck’s VirusExpress 293 AAV Production Platform: Merck’s platform aims to expedite process development and clinical manufacture, fostering market growth.

Thermo Fisher Scientific’s Strategic Acquisition:

• Expansion Initiatives: Thermo Fisher Scientific’s acquisition of Henogen S.A. aims to bolster global biomanufacturing capabilities, particularly in cell and gene therapies and vaccines.

Market Segmentation:

• Type: Segmented into Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, and Other Types.
• Disease: Categorized into Cancer, Genetic Disorders, Infectious Diseases, and Other Diseases.
• Workflow: Segmented into Upstream Processing and Downstream Processing.
• Application: Includes Gene and Cell Therapy Development, Vaccine Development, Biopharmaceutical and Pharmaceutical Discovery, and Biomedical Research.
• End-User: Encompasses Research Organizations, Biotech and Pharmaceutical Companies, and Others.

Regional Insights:

• North America: Emerged as the largest region in the viral vector manufacturing market in 2023.
• Asia-Pacific: Expected to witness the fastest growth in the forecast period, highlighting the global expansion of manufacturing facilities.

Conclusion: The viral vector manufacturing market’s remarkable growth trajectory is underpinned by factors such as technological innovations, rising disease prevalence, and strategic initiatives by key players. As the market continues to evolve, collaborations, regulatory compliance, and product innovations will remain pivotal in shaping its future landscape.

Request A Sample Of The Global Viral Vector Manufacturing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=12398&type=smp